热门资讯> 正文
Kymera Therapeutics宣布拟议承销发行
2024-08-20 04:10
- Kymera Therapeutics (NASDAQ:KYMR) commenced an underwritten public offering of $200M of shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock.
- Kymera intends to grant the underwriters a 30-day option to purchase up to an additional $30M of shares of its common stock at the public offering price per share, less underwriting discounts and commissions.
- Source: Press Release
More on Kymera Therapeutics
- Kymera Therapeutics, Inc. (KYMR) Q2 2024 Earnings Call Transcript
- Kymera Therapeutics: Solid Progress And No Change To My 'Buy' Rating
- Kymera Therapeutics GAAP EPS of -$0.58 beats by $0.12, revenue of $25.7M beats by $13.15M
- Biggest stock movers today: BP, INTC, HELE, and more
- Seeking Alpha’s Quant Rating on Kymera Therapeutics
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
